FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2521594860> ?p ?o ?g. }

• W2521594860 endingPage "71150" @default.
• W2521594860 startingPage "71136" @default.
• W2521594860 abstract "// Moshe Shashar 1 , Jamaica Siwak 1 , Umit Tapan 2 , Shin Yin Lee 2 , Rosana D. Meyer 3 , Paige Parrack 1 , Josenia Tan 3 , Fatemeh Khatami 1 , Jean Francis 1 , Qing Zhao 3 , Kevan Hartshorn 2 , Vijaya B. Kolachalama 4,5 , Nader Rahimi 3 and Vipul Chitalia 1,4 1 Department of Medicine, Boston University School of Medicine, Boston, MA, USA 2 Department of Medicine, Hematology-Oncology Section, Boston University School of Medicine, Boston, MA, USA 3 Department of Pathology, Boston University School of Medicine, Boston, MA, USA 4 Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, MA, USA 5 Cardiovascular Division, Brigham and Women’s Hospital, Boston, MA, USA Correspondence to: Vipul Chitalia, email: // Keywords : colorectal cancer, Cbl, Wnt Received : June 16, 2016 Accepted : August 21, 2016 Published : September 20, 2016 Abstract Despite the loss of Adenomatous Polyposis Coli ( APC ) in a majority of colorectal cancers (CRC), not all CRCs bear hallmarks of Wnt activation, such as nuclear β-catenin. This underscores the presence of other Wnt regulators that are important to define, given the pathogenic and prognostic roles of nuclear β-catenin in human CRC. Herein, we investigated the effect of Casitas B-lineage lymphoma (c-Cbl) on nuclear β-catenin, which is an oncoprotein upregulated in CRC due to loss-of-function APC or gain-of-function CTNNB1 mutations. Despite mechanistic rationale and recent discoveries of c-Cbl’s mutations in solid tumors, little is known about its functional importance in CRC. Our study in a cohort of human CRC patients demonstrated an inverse correlation between nuclear β-catenin and c-Cbl. Further investigation showed that the loss of c-Cbl activity significantly enhanced nuclear β-catenin and CRC tumor growth in cell culture and a mouse xenograft model. c-Cbl interacted with and downregulated β-catenin in a manner that was independent of CTNNB1 or APC mutation status. This study demonstrates a previously unrecognized function of c-Cbl as a negative regulator of CRC." @default.
• W2521594860 created "2016-09-30" @default.
• W2521594860 creator A5003969045 @default.
• W2521594860 creator A5014688092 @default.
• W2521594860 creator A5016630150 @default.
• W2521594860 creator A5025973279 @default.
• W2521594860 creator A5029457025 @default.
• W2521594860 creator A5029730540 @default.
• W2521594860 creator A5031505899 @default.
• W2521594860 creator A5039029079 @default.
• W2521594860 creator A5050700218 @default.
• W2521594860 creator A5055080226 @default.
• W2521594860 creator A5070931622 @default.
• W2521594860 creator A5086128059 @default.
• W2521594860 creator A5086663143 @default.
• W2521594860 creator A5091070295 @default.
• W2521594860 date "2016-09-20" @default.
• W2521594860 modified "2023-10-11" @default.
• W2521594860 title "c-Cbl mediates the degradation of tumorigenic nuclear β-catenin contributing to the heterogeneity in Wnt activity in colorectal tumors" @default.
• W2521594860 cites W1958512987 @default.
• W2521594860 cites W1972093511 @default.
• W2521594860 cites W1975669964 @default.
• W2521594860 cites W1979521719 @default.
• W2521594860 cites W1980627480 @default.
• W2521594860 cites W1982660067 @default.
• W2521594860 cites W1984353621 @default.
• W2521594860 cites W1992070409 @default.
• W2521594860 cites W1997533142 @default.
• W2521594860 cites W2000067057 @default.
• W2521594860 cites W2001102844 @default.
• W2521594860 cites W2001258296 @default.
• W2521594860 cites W2006795857 @default.
• W2521594860 cites W2011463708 @default.
• W2521594860 cites W2018425992 @default.
• W2521594860 cites W2020903392 @default.
• W2521594860 cites W2028876548 @default.
• W2521594860 cites W2029890460 @default.
• W2521594860 cites W2035816489 @default.
• W2521594860 cites W2038078260 @default.
• W2521594860 cites W2042386784 @default.
• W2521594860 cites W2044625635 @default.
• W2521594860 cites W2047717400 @default.
• W2521594860 cites W2053850923 @default.
• W2521594860 cites W2058194940 @default.
• W2521594860 cites W2059037016 @default.
• W2521594860 cites W2087615949 @default.
• W2521594860 cites W2095495579 @default.
• W2521594860 cites W2095692554 @default.
• W2521594860 cites W2096483233 @default.
• W2521594860 cites W2102600746 @default.
• W2521594860 cites W2104599144 @default.
• W2521594860 cites W2106204137 @default.
• W2521594860 cites W2110243528 @default.
• W2521594860 cites W2113724152 @default.
• W2521594860 cites W2125251546 @default.
• W2521594860 cites W2130753161 @default.
• W2521594860 cites W2137573050 @default.
• W2521594860 cites W2140479839 @default.
• W2521594860 cites W2142415827 @default.
• W2521594860 cites W2150008120 @default.
• W2521594860 cites W2154142498 @default.
• W2521594860 cites W2163008314 @default.
• W2521594860 cites W2171996338 @default.
• W2521594860 cites W2179604064 @default.
• W2521594860 cites W2275032079 @default.
• W2521594860 cites W3198353739 @default.
• W2521594860 cites W338487925 @default.
• W2521594860 doi "https://doi.org/10.18632/oncotarget.12107" @default.
• W2521594860 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5342068" @default.
• W2521594860 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27661103" @default.
• W2521594860 hasPublicationYear "2016" @default.
• W2521594860 type Work @default.
• W2521594860 sameAs 2521594860 @default.
• W2521594860 citedByCount "24" @default.
• W2521594860 countsByYear W25215948602017 @default.
• W2521594860 countsByYear W25215948602018 @default.
• W2521594860 countsByYear W25215948602019 @default.
• W2521594860 countsByYear W25215948602020 @default.
• W2521594860 countsByYear W25215948602022 @default.
• W2521594860 countsByYear W25215948602023 @default.
• W2521594860 crossrefType "journal-article" @default.
• W2521594860 hasAuthorship W2521594860A5003969045 @default.
• W2521594860 hasAuthorship W2521594860A5014688092 @default.
• W2521594860 hasAuthorship W2521594860A5016630150 @default.
• W2521594860 hasAuthorship W2521594860A5025973279 @default.
• W2521594860 hasAuthorship W2521594860A5029457025 @default.
• W2521594860 hasAuthorship W2521594860A5029730540 @default.
• W2521594860 hasAuthorship W2521594860A5031505899 @default.
• W2521594860 hasAuthorship W2521594860A5039029079 @default.
• W2521594860 hasAuthorship W2521594860A5050700218 @default.
• W2521594860 hasAuthorship W2521594860A5055080226 @default.
• W2521594860 hasAuthorship W2521594860A5070931622 @default.
• W2521594860 hasAuthorship W2521594860A5086128059 @default.
• W2521594860 hasAuthorship W2521594860A5086663143 @default.
• W2521594860 hasAuthorship W2521594860A5091070295 @default.
• W2521594860 hasBestOaLocation W25215948601 @default.
• W2521594860 hasConcept C121608353 @default.
• W2521594860 hasConcept C126322002 @default.

• next